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Abstract Vitamin D is lipophilic and accumulates substantially in adipose tissue. Even
without supplementation, the amount of vitamin D in the adipose of a typical
adult is equivalent to several months of the daily reference nutrient intake (RNI).
Paradoxically, despite the large amounts of vitamin D located in adipose tissue,
individuals with obesity are often vitamin D deficient according to consensus
measures of vitamin D status (serum 25-hydroxyvitamin D concentrations). Thus,
it appears that vitamin D can become ‘trapped’ in adipose tissue, potentially due
to insufficient lipolytic stimulation and/or due to tissue dysfunction/adaptation
resulting from adipose expansion. Emerging evidence suggests that exercise may
mobilise vitamin D from adipose (even in the absence of weight loss). If exercise
helps to mobilise vitamin D from adipose tissue, then this could have important
ramifications for practitioners and policymakers regarding the management of low
circulating levels of vitamin D, as well as chronically low levels of physical
activity, obesity and associated health conditions. This perspective led us to design
a study to examine the impact of exercise on vitamin D status, vitamin D turnover
and adipose tissue vitamin D content (the VitaDEx project). The VitaDEx project
will determine whether increasing physical activity (via exercise) represents a
potentially useful strategy to mobilise vitamin D from adipose tissue.
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Introduction
Vitamin D has effects far beyond its classical actions
on calcium homeostasis and bone metabolism, and
vitamin D insufficiency is thought to affect many phys-
iological systems and a wide array of human health
outcomes (Dobnig et al. 2008; Ginde et al. 2009;
Semba et al. 2010). Vitamin D status is conventionally
determined by measuring concentrations of the main
circulating form of vitamin D, 25-hydroxyvitamin D
[25(OH)D]. Approximately 30–40% of the UK popu-
lation have circulating 25(OH)D <25 nmol/l in winter
(SACN 2016), and the correction of low systemic con-
centrations of 25(OH)D is a recognised public health
priority (Palacios & Gonzalez 2014; Cashman et al.
2016).
Vitamin D: Overview
The two main forms of vitamin D are vitamin D2
(ergocalciferol) and vitamin D3 (cholecalciferol)
(Askew et al. 1930; Windaus et al. 1936). Previtamin
D3 is synthesised by the skin when solar ultraviolet
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(UV) radiation (wavelength 290–320 nm) penetrates
the skin and is absorbed by 7-dehydrocholesterol
(Maclaughlin et al. 1982), before spontaneously and
rapidly isomerising to vitamin D3. Vitamin D3 is meta-
bolised in the liver to 25(OH)D – the main circulating
form of vitamin D (Blunt et al. 1968; Blunt & Deluca
1969). Vitamin D2 and vitamin D3 can be obtained
from the diet and from supplements (Holick 2007).
Vitamin D2 is synthesised by UV irradiation of ergos-
terol and intake is primarily through consumption of
UV-irradiated mushrooms or supplements. In contrast,
vitamin D3 is more widely distributed in foods and is
more commonly used in supplements and fortified
foods than vitamin D2. One reason for using serum 25
(OH)D as a measure of vitamin D status is that it has
a half-life of ~2–3 weeks and, therefore, quantification
of this metabolite is not influenced by transient
changes in dietary vitamin D or acute sun exposure to
the same extent as other vitamin D metabolites (Jones
et al. 2015). The methods of assessing 25(OH)D are
reviewed by Le Goff et al. (2015). In this review, ref-
erence to ‘vitamin D’ denotes either vitamin D3 (chole-
calciferol) or 25(OH)D.
The main metabolically active form of vitamin D
in vivo is the seco-steroid 1,25-dihydroxyvitamin D
[1,25(OH)2D], also referred to as calcitriol. It is 1,25
(OH)2D that is generally considered responsible for
the physiological functions of vitamin D. The produc-
tion of 1,25(OH)2D takes place predominantly in the
kidney, and its action is mediated through binding to
a vitamin D receptor (VDR), which is usually located
in the nuclei of target cells, and which regulates target
gene expression when bound with 1,25(OH)2D (Haus-
sler et al. 2013). Study of VDR-ablated mice has
demonstrated numerous functions of vitamin D (Bouil-
lon et al. 2013).
Vitamin D binding protein (DBP) in serum binds to
different vitamin D metabolites with different affinity
(Daiger et al. 1975). Vitamin D is bound to DBP for
transport to relevant tissues and to regulate bioavail-
ability (Safadi et al. 1999). Normally ~85% of circu-
lating 1,25(OH)2D is bound to DBP, with ~0.4%
being free circulating (Bikle et al. 1984, 1985), and
~88% of circulating 25(OH)D is bound to DBP with
~0.04% free (Bikle et al. 1986). Vitamin D can also
be bound to albumin and chylomicrons of lipoproteins
at lower affinity (Haddad et al. 1993). Although the
majority of circulating vitamin D metabolites are
bound to DBP or albumin, there is currently consider-
able debate about whether bound or unbound forms
of vitamin D are biologically active (Bikle et al.
2017), with some tissues requiring uptake of
DBP-bound vitamin D and others appearing to access
free or unbound vitamin D (Chun et al. 2014).
Potentially meaningful quantities of vitamin D have
been observed in the skin, liver, skeletal muscle and
adipose tissue of humans (Mawer et al. 1972), with
evidence that extra-renal tissues (such as the placenta)
are capable of metabolising vitamin D (Weisman et al.
1979; Adams & Hewison 2012). The present review
will focus on the role of adipose tissue, exploring the
accumulation of vitamin D in this sizeable depot,
whilst also exploring the potential mechanisms under-
lying the mobilisation of vitamin D from adipose
within the context of well-established physiological
concepts.
Vitamin D accumulation in adipose
Vitamin D is lipophilic and early studies used radioac-
tive isotopes to demonstrate its accumulation in adi-
pose tissue (Rosenstreich et al. 1971; Mawer et al.
1972). Supplementing with 20 000 international units
(IU) of vitamin D3 per week for 3–5 years leads to a
substantial increase in vitamin D3 content in subcuta-
neous abdominal adipose tissue, approximately sixfold
greater than placebo (Didriksen et al. 2015). The
amount of 25(OH)D present in adipose explants
remained correlated with serum 25(OH)D concentra-
tions 1 year after supplementation had ceased (Marti-
naityte et al. 2017). Although it is worth noting that
values for serum 25(OH)D and adipose tissue vitamin
D3 measured in this study varied considerably between
participants, which may be explained by the fourfold
variation in body fat mass across the study popula-
tion. There is a positive linear correlation between
vitamin D3 concentrations in subcutaneous abdominal
adipose tissue and serum (Blum et al. 2008b). High
concentrations of vitamin D3 have been observed in
adipose tissue from various sites (perirenal, pericar-
dial, axillary and cervical) taken from humans who
were not known to be supplementing with vitamin D
(Lawson et al. 1986). Vitamin D storage was highly
variable between adipose depots (Lawson et al. 1986),
which may be driven by depot-specific differences in
adipose tissue blood flow or metabolism; differences
which have been identified when comparing subcuta-
neous abdominal adipose and gluteofemoral adipose
(Manolopoulos et al. 2010). Furthermore, the relative
amount of vitamin D (i.e. per gram of subcutaneous
abdominal adipose tissue) is highly variable between
individuals (Blum et al. 2008b; Pramyothin et al.
2011). It has recently been suggested that vitamin D
accumulates in greater concentrations in omental
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adipose than subcutaneous abdominal adipose (Car-
relli et al. 2017). However, given that the mass of sub-
cutaneous adipose tissue is fourfold to sixfold greater
than that of visceral adipose tissue (Ross et al. 2000;
Merlotti et al. 2017), the absolute capacity and accu-
mulation of vitamin D in subcutaneous adipose depots
is likely to be quantitatively more important. Nonethe-
less, further research is needed to understand both the
distribution and inter-/intra-individual variability of
vitamin D accumulation across different adipose
depots.
Whilst adipose can accumulate both vitamin D3 and
25(OH)D, the limited data available suggest that the
concentrations of vitamin D3 are much greater (Piccolo
et al. 2013; Didriksen et al. 2015). Published values for
the amount of vitamin D3 present in subcutaneous adi-
pose tissue vary substantially, ranging from ~4 to
~500 ng/g, suggesting large individual variability and
dependency on supplementation status (Didriksen et al.
2015). For an individual weighing 100 kg, with 40%
body fat, this may equate to 160–20 000 lg vitamin
D3, which is the equivalent to anywhere between 16
and 2000 days of the daily reference nutrient intake
(RNI) of total dietary vitamin D (10 lg) for the UK
population (Fig. 1). The median value for vitamin D3 in
adipose of non-supplementing humans with overweight
or obesity is 32 ng/g (Didriksen et al. 2015), which
equates to 128 days of the RNI. Thus, adipose tissue
has the potential to accumulate a substantial amount of
vitamin D, especially when adipose mass is expanded
(i.e. in overweight and obesity).
Obesity and vitamin D status
Individuals with obesity have lower circulating 25(OH)
D concentrations than individuals without obesity
(Compston et al. 1981; Bell et al. 1985; Liel et al.
1988; Vimaleswaran et al. 2013; Pereira-Santos et al.
2015; Walsh et al. 2016). The mechanisms explaining
this have been debated. One suggestion is that reduced
sunlight exposure is a behavioural tendency in individu-
als with obesity (Compston et al. 1981), but there is
limited empirical evidence to support this. Wortsman
et al. (2000) found that increases in serum 25(OH)D,
induced by UV exposure, were attenuated in individuals
with obesity, hypothesising that vitamin D is less
bioavailable because it is sequestered in the expanded
adipose tissue compartment. In support of this sugges-
tion, in individuals supplemented with 700 IU/day of
vitamin D for a year, the increase in serum 25(OH)D
was inversely related to body mass index (BMI) (Blum
et al. 2008a). Another study assessed serum 25(OH)D
responses across 90 days with ingestion of a single oral
bolus of 300 000 IU of vitamin D3 and showed that the
increase in serum 25(OH)D concentration was blunted
in individuals with overweight or obesity compared
with lean controls (Camozzi et al. 2016). Lower vita-
min D status has sometimes been attributed to volumet-
ric dilution, with regression analysis revealing body
mass as the strongest univariate predictor of vitamin D
status (Drincic et al. 2012). If volumetric dilution was
driving this observation, then lower vitamin D status
may also be associated with expansion of muscle (and
total) mass. However, when comparing winter levels
of serum 25(OH)D in a range of non-supplementing
athletes (rugby league players), significantly greater
mean serum 25(OH)D was observed compared with
non-supplementing, non-athlete controls despite mark-
edly greater body mass (reflective of large muscle mass)
(Close et al. 2013). Furthermore, in university athletes,
fat mass was a significant predictor of serum 25(OH)D
concentrations but fat-free mass was not (Heller et al.
2015). Collectively, these findings indicate that volu-
metric dilution per se does not explain the negative
associations between mass and vitamin D status. This
makes sense when considering the lipophilic nature of
vitamin D. Indeed, it seems likely that the detrimental
effect of obesity on vitamin D status is predominantly
due to specific expansion of adipose mass rather than
expansion of total mass or volume.
Early studies postulated that increased circulating
1,25(OH)2D with obesity reduces serum 25(OH)D by
reducing hepatic synthesis of 25(OH)D via negative
feedback (Bell et al. 1984, 1985). However, there is a
weak negative relationship between fat mass and cir-
culating 1,25(OH)2D (Parikh et al. 2004), calling into
question the existence of a negative feedback mecha-
nism by which production and accumulation of excess
1,25(OH)2D would reduce 25(OH)D synthesis. Alter-
natively, low circulating vitamin D in individuals with
Figure 1 The amount of vitamin D present in adipose tissue is likely to be
quantitatively important. When extrapolated, the amounts of vitamin D pre-
sent in the adipose tissue of an individual weighing 100 kg and with a body
fat percentage of 40% may equate to up to 2000 days of the daily recom-
mended nutrient intake (RNI) of vitamin D (10 lg) from dietary sources or
supplementation. [Colour ﬁgure can be viewed at wileyonlinelibrary.com]
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obesity may be attributable to increased metabolic
clearance and enhanced uptake of vitamin D by adi-
pose tissue (Liel et al. 1988). An upregulation of
enzymes responsible for metabolising 25(OH)D to
1,25(OH)2D is unlikely to contribute to decreased
serum 25(OH)D because of the significantly lower cir-
culating levels of 1,25(OH)2D relative to 25(OH)D
(~1:400) (Lips 2007). Wamberg et al. (2013) analysed
the expression of a number of vitamin D hydroxylases
in visceral and subcutaneous abdominal adipose tissue
of lean women and women with obesity. There was
no difference in CYP24A1 expression (a major enzyme
responsible for catabolising vitamin D) between lean
individuals and individuals with obesity. Similar
results have since been replicated in a cohort of indi-
viduals with obesity (Di Nisio et al. 2017). Together,
these studies suggest that CYP2J2-25-hydroxylation
and 1a-hydroxylation are impaired, rather than upreg-
ulated, in the adipose tissue of individuals with obe-
sity, so do not support the idea that the decreased
systemic 25(OH)D concentrations observed in obesity
are caused by increased metabolism of vitamin D in
adipose. Other recent investigations using stable iso-
topes indicate that there is no difference in the overall
25(OH)D half-life with obesity (Walsh et al. 2016).
Therefore, adipose does not seem to actively metabo-
lise more vitamin D in individuals with obesity and
there seems to be no effect of obesity on overall 25
(OH)D metabolism and turnover. Instead, the most
striking effect of obesity seems to be that adipose
becomes a sink or reservoir for vitamin D.
A role for vitamin D within adipose?
Adipose tissue comprises heterogeneous cells including
adipocytes, various immune cells and preadipocytes.
The cellular composition of adipose impacts on adi-
pose inflammation (Bourlier et al. 2008) and the secre-
tion of inflammatory mediators (Maury & Brichard
2010), which is particularly pertinent to individuals
with obesity as it contributes to systemic low-grade
inflammation (Trim et al. 2018).
Treatment of human adipocytes in vitro with 1,25
(OH)2D decreases secretion of interleukin 6 (Mutt et al.
2012), suggesting that 1,25(OH)2D inhibits phosphory-
lation of IкBa, which has an inhibitory effect on NF-кB
(Baeuerle & Baltimore 1988). NF-кB induces transcrip-
tion of pro-inflammatory pathways (Baldwin 1996), so
vitamin D is potentially anti-inflammatory for adipose
tissue if available to exert physiological actions. Vita-
min D might also be important for the formation of
new adipocytes, and this has been reviewed in detail
elsewhere (Dix et al. 2018). Peroxisome proliferator-
activated receptor gamma (PPARc) is thought to be the
‘master regulator’ of adipogenesis, with differentiation
maintained by concomitant expression of PPARc and
CCAAT enhancer-binding protein a (Rosen et al.
2002). Study of human preadipocytes suggests 1,25
(OH)2D promotes adipogenesis (Nimitphong et al.
2012). Narvaez et al. (2013) found similar effects in
human mesenchymal progenitor cells (hMPCs), where
1,25(OH)2D increased expression of adipogenic marker
genes including fatty acid synthase, fatty acid-binding
proteins and PPARc.
In vitro studies provide intriguing insights into
potential functions of vitamin D within adipose tissue
itself. Unfortunately, very little is known about the
amount/distribution of vitamin D metabolites and the
actions of 1,25(OH)2D in adipose tissue in vivo. Fur-
thermore, it is important to note that simple measure-
ment of vitamin D3 or 25(OH)D in adipose biopsy
samples does not reveal the extent to which active
1,25(OH)2D is available for biological activity.
The potentially positive effects of vitamin D on adi-
pose tissue physiology and function present a very
interesting avenue for further research. However, since
vitamin D is likely sequestered in lipid droplets of adi-
pocytes, it might only be expected to exert physiologi-
cal effects within adipose once mobilised into the
cytosol and/or interstitium. It is an intriguing paradox
that, in individuals with obesity, vitamin D seems to
be ‘trapped’ in the lipid droplets of adipocytes in very
close proximity to sites that may potentially benefit if
only it could be made bioavailable.
Physical activity/exercise and vitamin D
status
Physical activity is a powerful stimulus for lipid mobili-
sation from adipose tissue (Thompson et al. 2012). It
is therefore conceivable that vitamin D ‘trapped’ in
adipocytes is mobilised (along with stored lipid) by
physical activity. In support of this suggestion, associa-
tion studies consistently report greater serum 25(OH)D
concentrations in individuals who self-report higher
physical activity (Reinehr et al. 2007; Villareal et al.
2008; Chomistek et al. 2011; Mason et al. 2011; Gan-
gloff et al. 2015; Chin et al. 2017). One study using
objective measures of physical activity (hip-based
accelerometry) showed a trend for increased serum 25
(OH)D at higher physical activity levels (Klenk et al.
2015). Such associations have often been attributed to
confounding factors (e.g. active people spending more
time outside and receiving additional sunlight
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exposure), but recent studies indicate that exercise may
have a direct and causal effect on vitamin D status.
Spoo et al. (2015) found a progressive increase in
serum 25(OH)D in sled dogs performing prolonged
endurance exercise across 8 days. Dietary vitamin D
intake was controlled, there was no weight loss, and
confounding from sunlight exposure was mitigated by
the dogs’ thick fur coats (How et al. 1994). Further-
more, Sun et al. (2017) showed elevated serum 25
(OH)D concentrations in lean humans in response to
30 minutes of cycling exercise at 70% _VO2 peak
(Fig. 2a,b). The increase in circulating 25(OH)D was
observed immediately post-exercise and persisted for
24 hours. Interestingly, the strongest positive predictor
of increased 25(OH)D (incremental area under the
curve) across 24 hours was higher body fat percentage
(with no such relationship with fat-free mass). More
recently, the same group reported that 5 weeks of pro-
gressive endurance cycling exercise (30 minute bouts,
three bouts/week, 60–75% _VO2 peak) during winter
months prevented any reductions in serum 25(OH)D
concentrations in a small group of elderly men (Sun
et al. 2018) (Fig. 2c,d), independent from any changes
in adipose tissue mass. Collectively, these recent studies
indicate that exercise has a direct and causal effect on
25(OH)D concentrations – possibly through the mobil-
isation of adipose-derived vitamin D and/or 25(OH)D.
Lipolysis as a key mechanism of vitamin D
mobilisation with exercise?
During exercise, there is a rise in plasma glucagon,
adrenaline and atrial natriuretic peptide (ANP) (Galbo
et al. 1975; Bloom et al. 1976; Gyntelberg et al.
1977; Jezova et al. 1985; McMurray et al. 1987;
Moro et al. 2007) and a decrease in plasma insulin
(Hodgetts et al. 1991), concomitant with increased
adipose tissue blood flow (Thompson et al. 2012).
Glucagon, adrenaline and ANP are stimulatory lipoly-
tic hormones (Arner et al. 1990; Perea et al. 1995;
Moro et al. 2007) and suppression of insulin leads to
a potent increase in lipolysis (Jensen et al. 1989). This
leads to hydrolysis of triacylglycerol from the lipid
droplet of adipocytes by the action of adipose triglyc-
eride lipase (ATGL) (Jenkins et al. 2004; Villena et al.
2004; Zimmermann et al. 2004) and hormone-sensi-
tive lipase (HSL) (Vaughan et al. 1964). Exercise in
the fasted or the fed state leads to an approximate
twofold to threefold increase in adipose tissue lipolysis
(Wolfe et al. 1990; Klein et al. 1994; Enevoldsen et al.
2004) and, when stored triacylglycerol is hydrolysed,
vitamin D metabolites may also be released from the
lipid droplet (Fig. 3).
The lipolytic response of adipose tissue to exercise is
impaired in individuals with obesity. Ex vivo adipose
tissue explants from individuals with obesity display
reduced maximal lipolytic responses to adrenergic
stimulation compared with adipose from individuals
without obesity (Reynisdottir et al. 1994; Large et al.
1999; Hellstrom & Reynisdottir 2000), coinciding
with decreased gene expression of ATGL and HSL
(Large et al. 1999; Langin et al. 2005; Jocken et al.
2007; McQuaid et al. 2011). These findings are sup-
ported in vivo, as individuals with obesity display
lower rates of lipolysis during exercise than lean con-
trols (Stich et al. 2000; Mittendorfer et al. 2004).
Whilst this may protect individuals with obesity from
Figure 2 (a) The effect of 30 minutes of cycling exercise at 70%
_VO2 max on serum 25(OH)D concentrations in humans [redrawn using
data from Sun et al. (2017)]. Data shown are mean  standard error of the
mean (SEM) for men and women combined. (b) Mean change in serum 25
(OH)D concentrations following 30 minutes of cycling exercise at 70%
_VO2 max. Left-hand bar represents change from pre-exercise to immediately
post-exercise, right-hand bar represents change from pre-exercise to 24 hours
post-exercise [redrawn using data from Sun et al. (2017)]. (c) The effect of
5 weeks of progressive cycling endurance exercise (30 minute bouts,
3 bouts/week, from 60% to 75% _VO2 peak) during winter months on serum
25(OH)D [redrawn using data from Sun et al. (2018)]. Data shown are mean
SEM. (d) Mean change in serum 25(OH)D concentrations following
5 weeks of progressive cycling endurance exercise [redrawn using data from
Sun et al. (2018)]. [Colour ﬁgure can be viewed at wileyonlinelibrary.com]
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elevated circulating fatty acids (McQuaid et al. 2011),
it may also contribute to sequestration of vitamin D.
In support of this contention, adipose explants taken
from individuals with obesity release less vitamin D
when stimulated with lipolytic hormones than explants
from lean controls (Di Nisio et al. 2017). In this study,
mobilisation of vitamin D was proportional to both
the lipolytic response (glycerol release) and protein
expression of beta-adrenergic receptors (Di Nisio et al.
2017); further supporting the notion that vitamin D
mobilisation is inherently coupled to lipolysis.
Exercise may also target adipose tissue dysfunction
in obesity. It is well established that an increase in
physical activity chronically improves adipocyte
function (Thompson et al. 2012). Exercise training
increases sensitivity to various mediators such as insu-
lin and adrenaline in overweight/obese adipose tissue
(Thompson et al. 2012). It has also recently been
shown that trained individuals exhibit greater protein
content of lipolytic enzymes in subcutaneous abdomi-
nal adipose tissue (Bertholdt et al. 2018). Thus, in
addition to an acute effect on vitamin D release asso-
ciated with each exercise bout, regular exercise
improves adipocyte function and the capacity to
respond when stimulated, which may include the
capacity to mobilise vitamin D in response to multiple
stimuli (e.g. habitual physical activity, fasting and
stress).
Figure 3 Vitamin D and the adipocyte. We hypothesise that in the rested or fed state triacylglycerol and vitamin D metabolites are trapped in the lipid droplet
of adipocytes. When exposed to a lipolytic stimulus, triacylglycerol is liberated and this may coincide with mobilisation of vitamin D metabolites. ATGL, adipose
triglyceride lipase; HSL, hormone-sensitive lipase, TAG, triacylglycerol. [Colour ﬁgure can be viewed at wileyonlinelibrary.com]
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The effect of exercise on vitamin D
mobilisation: The VitaDEx project
The UK Biotechnology and Biological Sciences
Research Council (BBSRC) recently supported the Vita-
DEx project (‘Mobilising Vitamin D sequestered in adi-
pose tissue in humans with Exercise’; running from
October 2018 to October 2021). In VitaDEx, we will
examine the impact of increased exercise on whole-
body and adipose tissue vitamin D metabolism, along
with the pathways involved in vitamin D mobilisation
from adipose tissue. We will use a 10-week randomised
controlled trial in overweight men and women to deter-
mine the impact of exercise (versus control) on vitamin
D status and metabolism. Multiple vitamin D metabo-
lites including vitamin D3, 25(OH)D3, 25(OH)D2,
active vitamin D [1,25-dihydroxyvitamin D, 1,25
(OH)2D3] and other metabolites such as 24,25-dihy-
droxyvitamin D [24,25(OH)2D3] and 3-epi-25(OH)D
will be measured in serum using liquid chromatogra-
phy–mass spectrometry (LC-MS/MS) (Jenkinson et al.
2016). Turnover of 25(OH)D will be assessed using an
established stable isotope technique (with measurement
by LC-MS/MS) (Jones et al. 2016; Walsh et al. 2016).
We will determine whether the change in serum 25
(OH)D has a demonstrable effect on functional mea-
sures of bioavailability by culturing monocytes from a
single donor with media supplemented with participant
serum to assess the impact of different serum vitamin D
concentrations on monocyte function. In addition, mea-
sures in subcutaneous abdominal adipose biopsies and
fluxes across adipose tissue (arteriovenous differences)
will be combined to understand the impact of exercise
on the capacity to mobilise vitamin D from adipose tis-
sue. The acquired tissue samples will enable us to char-
acterise the biological pathways and mechanisms that
are involved in vitamin D mobilisation. In addition to
the intervention study, we will include a lean compara-
tor group to understand the independent effects of adi-
posity and contextualise the effects of exercise on
vitamin D mobilisation, status and metabolism.
Variability in UV-induced vitamin D synthesis is a
potential risk during intervention studies and, there-
fore, we will structure the experimental work to take
place during the winter months when there is little
vitamin D synthesis at the latitude where the trial will
be conducted (Webb et al. 1988). This restriction in
time for experimental work necessitates a pragmatic
approach to study design; thus, a 10-week exercise
intervention has been chosen to increase the available
window of time for participants to commence the
trial. A 10-week exercise intervention is also long
enough to impact on key measures of adipose tissue
function (Thompson et al. 2012). Furthermore, we
anticipate that serum 25(OH)D will decline during
10 weeks in winter in non-exercising control partici-
pants, such that protective effects of an exercise inter-
vention will be apparent over this timeframe. Notably,
all exercise undertaken by the exercise group will
occur indoors. Participants in the exercise group will
perform cardiovascular exercise training four times
per week, predominantly in the form of treadmill
walking and cycling. Exercise duration will be pro-
gressive, at an intensity that will be personalised to
participants, predominantly corresponding to maximal
rates of fat oxidation.
Another potential risk during exercise interventions is
variability in energy balance and weight loss due to
varying degrees of dietary compensation (Turner et al.
2010), so we will compensate for the increase in energy
expenditure with food prescribed to fully offset the
energy expended during exercise (thus maintaining
energy balance). Energy expenditure will be monitored
during exercise to enable us to replace the energy
expended with foods containing no vitamin D, and we
will verify the adequacy of this energy replacement by
monitoring changes in body composition via dual X-ray
absorptiometry (DEXA). Dietary intake will be
recorded with a 3-day weighed diet record in the week
prior to, and during the final week of, the intervention,
along with a retrospective food frequency questionnaire
at both time points to more specifically capture dietary
sources of vitamin D habitually consumed.
Conclusions
Vitamin D can accumulate in large amounts in adi-
pose tissue where it may become sequestered. Prelimi-
nary evidence indicates that exercise may be a
potential strategy to mobilise vitamin D from adipose
tissue. We will examine this concept in a new research
study (the VitaDEx project). This research will help us
to understand the impact of exercise on vitamin D sta-
tus and whether increasing physical activity represents
a potentially useful strategy to mobilise vitamin D
from adipose tissue. If exercise helps to mobilise vita-
min D from adipose, then this could have important
ramifications for practitioners and policymakers
regarding the management of (i) low vitamin D status,
(ii) obesity and associated conditions and (iii) low
levels of physical activity. Current public health strate-
gies typically approach vitamin D deficiency by
increasing intake and/or synthesis of vitamin D (e.g.
dietary supplementation or UV treatment). Notably,
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overweight/obesity reduces the impact of dietary sup-
plementation with vitamin D on 25(OH)D concentra-
tions (Arunabh et al. 2003; Snijder et al. 2005; Blum
et al. 2008a; Beydoun et al. 2010) and the systemic
25(OH)D response to UV irradiation is significantly
impaired (Wortsman et al. 2000). Thus, complement-
ing conventional intake/synthesis strategies with tech-
niques to mobilise endogenous vitamin D has the
capacity to mutually enhance the overall effectiveness
of interventions to improve vitamin D status.
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